Xiaodong Zheng

3PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 21, 2024
CD49a Targeting Enhances NK Cell Function and Antitumor Immunity.

Yu Zhang, Yangyang Li, Zhengfeng Zhang

|Jul 11, 2024
The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling.

Yongjing Shi, Xiaodong Zheng, Hui Peng

Pageof 1